Adebrelimab Injection: Clinical Trials

6 trials of Adebrelimab Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 1 not yet recruiting. 6 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Recruiting 5, Not yet recruiting 1
Phase 25Recruiting 5

Follow Adebrelimab Injection: new trials by email Literature Review of Adebrelimab Injection trials Research Report on Adebrelimab Injection

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLC
HS-20093 for Injection, ZG006, Adebrelimab Injection - Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Phase 1Not yet recruitingHansoh BioMedical R&D Company3382026-11-152026-10-23
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
SHR-A1811, Carboplatin, Bevacizumab - Ovarian Cancer
Phase 1 / Phase 2RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.1502025-03-182026-09-11
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
SHR-1826, SHR-4642, SHR-9839 - Advanced Solid Tumors
Phase 1 / Phase 2RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.8762025-02-182025-12-03
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
SHR-A2102, Adebrelimab injection, SHR-8068 injection - Advanced Urothelial Carcinoma
Phase 1 / Phase 2RecruitingShanghai Hengrui Pharmaceutical Co., Ltd.902024-11-042024-11-18
A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
Adebrelimab - Gastric Cancer
Phase 1 / Phase 2RecruitingCancer Hospital Chinese Academy of Medical Science, Shenzhen Center522024-08-032025-01-15
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
SHR-A2102 for Injection, Adebrelimab Injection, Cisplatin injection - Advanced or Metastatic Non-small Cell Lung Cancer
Phase 1 / Phase 2RecruitingShanghai Hengrui Pharmaceutical Co., Ltd.2482024-07-302025-12-23

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Ovarian Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)  ·  Stomach Neoplasms (1)

Sponsors

Shanghai Hengrui Pharmaceutical Co., Ltd. (2)  ·  Suzhou Suncadia Biopharmaceuticals Co., Ltd. (2)  ·  Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center (1)  ·  Hansoh BioMedical R&D Company (1)

Countries

China (5)